Tg Therapeutics (TGTX) Return on Sales Growth (1y) (2018 - 2026)

Tg Therapeutics (TGTX) Return on Sales Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.84 Bn 467.05 Bn 1.35 Bn 0.00
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn 0.00
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 0.00
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 0.00
10 Tg Therapeutics 8.07 Bn 8.00 Bn 171.41 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 2.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 1.00
Sep 30, 2024 -1.00
Jun 30, 2024 3.00
Mar 31, 2024 5.00
Dec 31, 2023 1,047.00
Sep 30, 2023 436.00
Jun 30, 2023 92.00
Mar 31, 2023 32.00
Dec 31, 2022 -1,006.00
Sep 30, 2022 -385.00
Jun 30, 2022 -40.00
Mar 31, 2022 79.00
Dec 31, 2021 2,270.00
Sep 30, 2021 1.34 Mn
Jun 30, 2021 892,923.00